Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...

The Food and Drug Administration approved the first member of a new class of anti-HIV drugs yesterday, providing for the first time in seven years an entirely new mode of attacking the virus that ...

Share on Pinterest Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with HIV who are undergoing antiretroviral therapy. Francis ...

March 5 (Reuters) - The World Health Organization (WHO) said on Tuesday resistance to GSK's GSK.L HIV drug dolutegravir has exceeded levels observed during its trials, citing observational and survey ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...